<result><Target><Item><Target_ID> 2024</Target_ID>
<Target_Name>Complement decay-accelerating factor</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P08174</Target_Sequence>
<Synonyms>CD_antigen: CD55</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1H03, 1H04, 1H2P, 1H2Q, 1M11, 1NWV, 1OJV, 1OJW, 1OJY, 1OK1, 1OK2, 1OK3, 1OK9, 1UOT, 1UPN, 2C8I, 2QZD, 2QZF, 2QZH, 3IYP, 3J24, 5FOA</Target_Structure>
<Comments>CD55 molecule on the surface of human cervical cancer HeLa cell was the target.</Comments>
</Item><Item><Target_ID> 2025</Target_ID>
<Target_Name>Mast cell protease 2</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mesocricetus auratus (Golden hamster):10036</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2026</Target_ID>
<Target_Name>Mast cell protease 1</Target_Name>
<Target_Type>Protein&gt;Enzyme</Target_Type>
<Target_Sequence>A0A1U7R1S4</Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Mesocricetus auratus (Golden hamster):10036</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2027</Target_ID>
<Target_Name>Anti-GSFLSPEHQRVQ polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti ghrelin polyclonal antibodies (LifeSpan LS-B3661-50 RRID:AB_10633584) raised against synthetic peptide mapping to the N-terminus of the active human ghrelin containing amino acid GS(X)FLSPEHQRVQ (X = Ser modified with n-octanoic acid) were additionally affinity purified using full-length octanoylated human ghrelin (B-031-30, Phoenix Pharmacueticals, Karlsruhe, Germany) immobilized on streptavidin coated magnetic beads (MyOne Streptavidin T1, Life Technologies, Invitrogen, Carlsbad, CA, USA).</Comments>
</Item><Item><Target_ID> 2028</Target_ID>
<Target_Name>Anti N-terminal appetite-regulating hormone[24-51] polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Oryctolagus cuniculus (Rabbit):9986</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Rabbit anti N-terminal human ghrelin antibodies (Cat# LS-C4896-100, RRID:AB_862046) were provided by LifeSpan, RI, USA.</Comments>
</Item><Item><Target_ID> 2029</Target_ID>
<Target_Name>Anti C-terminal appetite-regulating hormone[24-51] polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Goat anti C-terminal human ghrelin antibodies (Cat# sc-10368, RRID:AB_2232479) were puchased from Santa Cruz Biotechnology, Dallas, TX, USA.</Comments>
</Item><Item><Target_ID> 2030</Target_ID>
<Target_Name>BDNF/NT-3 growth factors receptor (EC:2.7.10.1)[1-430]</Target_Name>
<Target_Type>Protein&gt;Receptor</Target_Type>
<Target_Sequence>Q16620</Target_Sequence>
<Synonyms>Alternative names for BDNF/NT-3 growth factors receptor (EC:2.7.10.1):
GP145-TrkB (Trk-B)
Neurotrophic tyrosine kinase receptor type 2
TrkB tyrosine kinase
Tropomyosin-related kinase B</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1HCF, 1WWB, 2MFQ, 4ASZ, 4AT3, 4AT4, 4AT5, 5MO9</Target_Structure>
<Comments>Phage displayed peptides were isolated against recombinant human NTRK2 (Fc‐His NTRK2) (Creative Biomart, New York, NY). Fc‐His NTRK2 is a fusion protein composed of the extracellular domain of the human NTRK2 receptor (Met1‐His430)(NP_001007098.1, transcript variant b) and the poly histidine‐tagged Fc region of human IgG1.</Comments>
</Item><Item><Target_ID> 2031</Target_ID>
<Target_Name>Endoglin</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P17813</Target_Sequence>
<Synonyms>CD_antigen: CD105</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>5HZV, 5HZW, 5I04</Target_Structure>
<Comments>The recombinant human CD105 protein was provided by R&amp;D Systems, Inc. (Minneapolis, MN). CD105, also referred to as endoglin, is a type I membrane glycoprotein that forms part of the TGF-β receptor complex on cell membranes. CD105 is a 180 kDa homodimeric transmembrane protein composed of 633 amino acids, which consists of a large extracellular domain, a hydrophobic transmembrane domain and a short intracellular domain. The CD105 external domain binds to the TGF-β1 and TGF-β3 isoforms with a high affinity, forming the TGF-β receptor complex. It serves an important role in regulating cellular proliferation, differentiation, migration, adhesion and angiogenesis, which are vital processes for tumour growth, survival and metastasis. CD105 is predominantly expressed in angiogenic endothelial cells, or blood vessels surrounding tumour tissues and mesenchymal stem cells (MSCs).</Comments>
</Item><Item><Target_ID> 2032</Target_ID>
<Target_Name>Rabbit anti-goat IgG (H + L) superclonal secondary antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source></Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2033</Target_ID>
<Target_Name>Ubiquitin carboxyl-terminal hydrolase 11 [1–244 or 24–244]</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P51784</Target_Sequence>
<Synonyms>Deubiquitinating enzyme 11
Ubiquitin thioesterase 11
Ubiquitin-specific-processing protease 11</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>4MEL</Target_Structure>
<Comments>USP11 harbours a core protease domain as well as non-catalytic regions containing an Nterminal domain present in USPs (DUSP) andinternal ubiquitin-like (UBL) domains.</Comments>
</Item><Item><Target_ID> 2034</Target_ID>
<Target_Name>The variant of photoactive yellow protein (PYP) in the light-state</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The variant of photoactive yellow protein (PYP) is designated cPYP19 in which the thermal relaxation to the dark state was slower than wild type to facilitate complete switching to the light state without requiring very bright light sources. The target light-switchable protein was expressed as a fusion to GST with an AviTag sequence to permit site-specific biotinylation during expression.</Comments>
</Item><Item><Target_ID> 2035</Target_ID>
<Target_Name>The variant of AsLOV2 in the dark-state</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>The variant of AsLOV2 is used as the target in which the thermal relaxation to the dark state was slower than wild type to facilitate complete switching to the light state without requiring very bright light sources. The target light-switchable protein was expressed as a fusion to GST with an AviTag sequence to permit site-specific biotinylation during expression.</Comments>
</Item><Item><Target_ID> 2036</Target_ID>
<Target_Name>Serum from patients with wasp sting injuries</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Serum was collected from ten patients (seven males and three females, with a mean age of 35.73 +/- 18.26 years) with wasp sting injuries at 3 h and 4 days after a wasp sting.</Comments>
</Item><Item><Target_ID> 2037</Target_ID>
<Target_Name>Chitosan</Target_Name>
<Target_Type>Organic molecules or materials</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Chitosan (Mw=30000, deacetylation degree≥95%) was provided by Kuer chemical technology Co., Ltd. (Beijing, China).</Comments>
</Item><Item><Target_ID> 2038</Target_ID>
<Target_Name>Anti-histamine H4 receptor (H4R) monoclonal antibody</Target_Name>
<Target_Type>Protein&gt;Monoclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2039</Target_ID>
<Target_Name>Ovarian cancer tissue slice</Target_Name>
<Target_Type>Organ and tissue</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unknown</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2040</Target_ID>
<Target_Name>Protein A</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Unkown</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Protein A-conjugated Sepharose was purchased from Pharmacia (Piscataway, New Jersey).</Comments>
</Item><Item><Target_ID> 2041</Target_ID>
<Target_Name>Goat anti-human IgM polyclonal antibody</Target_Name>
<Target_Type>Protein&gt;Polyclonal antibody</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Capra hircus (Goat):9925</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2042</Target_ID>
<Target_Name>Endothelial Progenitor Cell (EPC)</Target_Name>
<Target_Type>Cell</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure></Target_Structure>
<Comments>EPCs (Catalog #: Z7030001) were obtained from BioChain Institute Inc. (Newark, California, United States).</Comments>
</Item><Item><Target_ID> 2043</Target_ID>
<Target_Name>B1 peptide (CMSDWTGG)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments>Firstly, we synthesized the B1 peptide (CMSDWTGG) based on the sequence of the first extracellular loop of LMP1 which served to screen the peptide library (Ph.D.-C7C).</Comments>
</Item><Item><Target_ID> 2044</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P50339</Target_Sequence>
<Synonyms>Mast cell protease 3, rMCP-3
Mast cell protease 5, rMCP-5
Mast cell protease III, rMCP-III</Synonyms>
<Target_Source>Rattus norvegicus (Rat):10116</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2045</Target_ID>
<Target_Name>Mast cell protease 4 (EC:3.4.21.-), mMCP-4</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21812</Target_Sequence>
<Synonyms>MSMCP
Myonase
Serosal mast cell protease</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2046</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P21844</Target_Sequence>
<Synonyms>Alpha-chymase
Mast cell chymase 1
Mast cell protease 5
mMCP-5
Mast cell protease I</Synonyms>
<Target_Source>Mus musculus (Mouse):10090</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2047</Target_ID>
<Target_Name>Chymase (EC:3.4.21.39)</Target_Name>
<Target_Type>Protein&gt;Others</Target_Type>
<Target_Sequence>P23946</Target_Sequence>
<Synonyms>Alpha-chymase
Mast cell protease I</Synonyms>
<Target_Source>Homo sapiens (Human):9606</Target_Source>
<Target_Structure>1KLT, 1NN6, 1PJP, 1T31, 2HVX, 3N7O, 3S0N, 4AFQ, 4AFS, 4AFU, 4AFZ, 4AG1, 4AG2, 4K2Y, 4K5Z, 4K60, 4K69, 4KP0, 5YJM, 5YJP</Target_Structure>
<Comments></Comments>
</Item><Item><Target_ID> 2048</Target_ID>
<Target_Name>Pseudomonas aeruginosa ATCC 27853</Target_Name>
<Target_Type>Miscellaneous</Target_Type>
<Target_Sequence></Target_Sequence>
<Synonyms></Synonyms>
<Target_Source>None</Target_Source>
<Target_Structure></Target_Structure>
<Comments></Comments>
</Item></Target></result>